Table 4 Clinical characteristics of patients in different subgroups

From: The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG

 

Overall (n = 40)

WT (n = 14)

Single-Mut (n = 23)

Co-Mut (n = 3)

p

Age

 Mean (SD)

62.30 (9.17)

61.21 (7.24)

61.65 (10.01)

72.33 (5.51)

0.142

 Median [IQR]

63.00 [55.75, 68.25]

62.00 [55.25, 65.00]

62.00 [55.00, 68.50]

72.00 [69.50, 75.00]

Gender

 Female

8 (20.0)

2 (14.3)

6 (26.1)

0 (0.0)

0.457

 Male

32 (80.0)

12 (85.7)

17 (73.9)

3 (100.0)

Stage

 T1

34 (85.0)

12 (85.7)

19 (82.6)

3 (100.0)

0.870

 Ta

5 (12.5)

2 (14.3)

3 (13.0)

0 (0.0)

 Tis

1 (2.5)

0 (0.0)

1 (4.3)

0 (0.0)

Grade

 HG

34 (85.0)

12 (85.7)

19 (82.6)

3 (100.0)

0.870

Intermediate

1 (2.5)

0 (0.0)

1 (4.3)

0 (0.0)

 LG

5 (12.5)

2 (14.3)

3 (13.0)

0 (0.0)

Tumor percent

 Mean (SD)

50.75 (23.90)

43.57 (19.85)

50.87 (24.48)

83.33 (5.77)

0.028

 Median [IQR]

50.00 [37.50, 80.00]

40.00 [30.00, 50.00]

50.00 [40.00, 75.00]

80.00 [80.00, 85.00]

TMB

 Mean (SD)

9.47 (6.62)

9.54 (7.32)

8.63 (6.02)

15.62 (6.64)

0.232

 Median [IQR]

7.98 [4.99, 11.22]

6.98 [5.24, 11.46]

7.98 [4.99, 9.97]

18.94 [13.46, 19.44]

HDR score

 Mean (SD)

16.38 (15.19)

15.57 (13.73)

14.26 (14.14)

36.33 (20.55)

0.055

 Median [IQR]

13.00 [4.75, 22.25]

12.50 [8.00, 19.25]

12.00 [2.50, 21.00]

38.00 [26.50, 47.00]

Purity

 Mean (SD)

0.56 (0.24)

0.46 (0.25)

0.59 (0.24)

0.74 (0.06)

0.137

 Median [IQR]

0.48 [0.39, 0.80]

0.44 [0.26, 0.52]

0.52 [0.41, 0.83]

0.73 [0.71, 0.76]

Ploidy

 Mean (SD)

3.20 (2.92)

2.40 (0.79)

3.54 (3.68)

4.31 (2.55)

0.420

 Median [IQR]

2.00 [1.98, 3.91]

1.99 [1.97, 2.22]

2.00 [1.98, 3.95]

3.90 [2.95, 5.47]

nCIN

 Mean (SD)

4.12 (4.56)

3.71 (3.95)

3.70 (4.44)

9.33 (6.66)

0.120

 Median [IQR]

3.00 [1.00, 5.25]

3.50 [0.25, 4.00]

2.00 [1.00, 5.00]

11.00 [6.50, 13.00]

  1. WT wild type, Mut mutation, HG high grade, LG low grade, TMB tumor mutation burden, nCIN numerical chromosomal instability.